Concurrent epidemics of influenza A/H3N2 and A/H1N1pdm in Southern China: A serial cross-sectional study

Journal of Infection

Volumn 72, Issue 3, 2016, Pages 369-376

  Wu, Chunli ^a   Wang, Maggie Haitian ^b   Lu, Xing ^a   Chong, Ka Chun ^b   He, Jason ^c   Yau, Chun Yip ^b   Hui, Mark ^b   Cheng, Xiaowen ^a   Yang, Li ^d   Zee, Benny Chung Ying ^b   Zhang, Renli ^a   He, Ming Liang ^b,e  

^a SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SICHUAN UNIVERSITY   (China)

^e CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antibody response; Concurrent epidemics; Elderly; H1N1pdm; H3N2; Influenza

Indexed keywords

AMINO ACID; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

127 H3 GENE; 28 H1PDM GENE; ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIBODY RESPONSE; ARTICLE; CHILD; CHINA; CONCURRENT INFECTION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; GENE; GENE SEQUENCE; GROUPS BY AGE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A (H3N2); MAJOR CLINICAL STUDY; MALE; PHYLOGENY; SEROLOGY; VACCINATION; VIRUS STRAIN; AGED; BLOOD; DNA SEQUENCE; GENETICS; GENOTYPE; IMMUNOLOGY; INFANT; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; SEROEPIDEMIOLOGY; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; CROSS-SECTIONAL STUDIES; EPIDEMICS; FEMALE; GENOTYPE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84958256208     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.12.013     Document Type: Article

References (44)

1. World Health Organization Influenza (Seasonal) 2013, Available from:. http://www.who.int/mediacentre/factsheets/fs211/en/.
2. Bahl J., Nelson M.I., Chan K.H., Chen R., Vijaykrishna D., Halpin R.A., et al. Temporally structured metapopulation dynamics and persistence of influenza A H3N2 virus in humans. Proc Natl Acad Sci U S A 2011, 108(48):19359-19364.
3. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453(7195):615-619.
4. Nelson M.I., Holmes E.C. The evolution of epidemic influenza. Nat Rev Genet 2007, 8(3):196-205.
5. Viboud C., Alonso W.J., Simonsen L. Influenza in tropical regions. PLoS Med 2006, 3(4):468-471.
6. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008, 320(5874):340-346.
7. Sonoguchi T., Naito H., Hara M., Takeuchi Y., Fukumi H. Cross-subtype protection in humans during sequential, overlapping, and or concurrent epidemics caused by H3n2 and H1n1 influenza-viruses. J Infect Dis 1985, 151(1):81-88.
8. Finkelman B.S., Viboud C., Koelle K., Ferrari M.J., Bharti N., Grenfell B.T. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS One 2007, 2(12).
9. Wu C.L., Lu J., Wang M.H., Lv X., Chen Y., Kung H.F., et al. Cross sectional survey of influenza antibodies before and during the 2009 pandemic in Shenzhen, China. PLoS One 2013, 8(1).
10. Fielding J., Higgins N., Gregory J., Grant K., Catton M., Bergeri I., et al. Pandemic H1n1 influenza surveillance in Victoria, Australia, April-September, 2009. Eurosurveillance 2009, 14(42):37-44.
11. Chowell G., Bertozzi S.M., Colchero M.A., Lopez-Gatell H., Alpuche-Aranda C., Hernandez M., et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009, 361(7):674-679.
12. Lindstrom S., Garten R., Balish A., Shu B., Emery S., Berman L., et al. Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg Infect Dis 2012, 18(5):834-837.
13. Liu Q., Ma J., Liu H., Qi W., Anderson J., Henry S.C., et al. Emergence of novel reassortant H3N2 swine influenza viruses with the 2009 pandemic H1N1 genes in the United States. Arch Virol 2012, 157(3):555-562.
14. Nelson M.I., Detmer S.E., Wentworth D.E., Tan Y., Schwartzbard A., Halpin R.A., et al. Genomic reassortment of influenza A virus in North American swine, 1998-2011. J Gen Virol 2012, 93(Pt 12):2584-2589.
15. Broberg E., Snacken R., Adlhoch C., Beauté J., Galinska M., Pereyaslov D., et al. Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Eurosurveillance 2015, 20(4):2-6.
16. EMBL-EBI. Clustal Omega. Available from: . http://www.ebi.ac.uk/Tools/msa/clustalo/.
17. Felsenstein J. PHYLIP (phylogeny inference package) version 3.6 2005, Department of Genome Sciences, University of Washington, Seattle.
18. Kendal A.P., Pereira M., Skehel J. Concepts and procedures for laboratory-based influenza surveillance 1982, World Health Organization, Geneva.
19. Schweiger B., Zadow I., Heckler R., Timm H., Pauli G. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol 2000, 38(4):1552-1558.
20. Wu J.T., Ma E.S., Lee C.K., Chu D.K., Ho P.L., Shen A.L., et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010, 51(10):1184-1191.
21. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375(9720):1100-1108.
22. Kirkwood T.B.L. Geometric means and measures of dispersion. Biometrics 1979, 35(4):908-909.
23. Nauta J.J.P., de Bruijn I.A. On the bias in HI titers and how to reduce it. Vaccine 2006, 24(44-46):6645-6646.
24. Peacey M., Hall R.J., Sonnberg S., Ducatez M., Paine S., Nicol M., et al. Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009. Emerg Infect Dis 2010, 16(10):1618-1620.
25. Lee N., Chan P.K., Lam W.Y., Szeto C.C., Hui D.S. Co-infection with pandemic H1N1 and seasonal H3N2 influenza viruses. Ann Intern Med 2010, 152(9):618-619.
26. Liu D.J.J., Leal S.M. A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions. PLoS Genet 2010, 6(10).
27. McElhaney J.E., Gravenstein S., Upshaw C.M., Hooton J.W., Krause P., Drinka P. Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets. Vaccine 1998, 16(4):403-409.
28. Bender B.S., Johnson M.P., Small P.A. Influenza in senescent mice: impaired cytotoxic T-lymphocyte activity is correlated with prolonged infection. Immunology 1991, 72(4):514-519.
29. Shao T.J., Li J., Yu X.F., Kou Y., Zhou Y.Y., Qian X. Progressive antigenic drift and phylogeny of human influenza A(H3N2) virus over five consecutive seasons (2009-2013) in Hangzhou, China. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 2014, 29:190-193.
30. Merler S., Ajelli M., Camilloni B., Puzelli S., Bella A., Rota M.C., et al. Pandemic influenza A/H1N1pdm in Italy: age, risk and population susceptibility. PLoS One 2013, 8(10):e74785.
31. Epperson S., Jhung M., Richards S., Quinlisk P., Ball L., Moll M., et al. Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis Off Publ Infect Dis Soc Am 2013, 57(Suppl. 1):S4-S11.
32. Glezen W.P., Decker M., Joseph S.W., Mercready R.G. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. J Infect Dis 1987, 155(6):1119-1126.
33. Howells C.H., Vesselinova-Jenkins C.K., Evans A.D., James J. Influenza vaccination and mortality from bronchopneumonia in elderly. Lancet 1975, 1(7903):381-383.
34. Webster R.G. Immunity to influenza in the elderly. Vaccine 2000, 18(16):1686-1689.
35. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24(8):1159-1169.
36. Lessler J., Cummings D.A., Read J.M., Wang S., Zhu H., Smith G.J., et al. Location-specific patterns of exposure to recent pre-pandemic strains of influenza A in southern China. Nat Commun 2011, 2.
37. Ra M. Aging and immunity response. Handbook of the biology of aging 1996, 355-392. Academic Press, San Diego. J. Rowe, E. Schneider (Eds.).
38. McElhaney J.E. The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 2005, 23(Suppl. 1):S10-S25.
39. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19:65-91.
40. Wilson I.A., Skehel J.J., Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981, 289(5796):366-373.
41. Both G.W., Sleigh M.J., Cox N.J., Kendal A.P. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol 1983, 48(1):52-60.
42. Wiley D.C., Skehel J.J. The structure and function of the hemagglutinin membrane glycoprotein of influenza-virus. Annu Rev Biochem 1987, 56:365-394.
43. Stucker K.M., Schobel S.A., Olsen R.J., Hodges H.L., Lin X., Halpin R.A., et al. Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas. Eurosurveillance 2015, 20(18):20-34.
44. Barr I.G., Russell C., Besselaar T.G., Cox N.J., Daniels R.S., Donis R., et al. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine 2014, 32(37):4713-4725.